Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact
Search
Close
Enter Search Terms
Search
Jim Johnson
ID:
1b8379ff-2619-30fb-68c4
/
Unclaimed
/
Organization:
Hogan Lovells
Published Works
29 articles
Continuous Manufacturing of Pharmaceuticals: FDA Wants to Hear from Industry
Focus on Regulation ·
June 23, 2017
cite
U.S. FDA and EU Regulators Announce Enhanced Mutual Recognition for Pharmaceutical Manufacturing Inspections; Allows FDA to Continue Shifting Inspections and Enforcement Focus to Asia
Focus on Regulation ·
March 2, 2017
cite
FDA Clarifies Requirements Regarding Submission of Manufacturing Establishment Information
Focus on Regulation ·
January 6, 2017
cite
FDA Revises Its Drug Establishment Registration, Drug Listing, and National Drug Code (NDC) Regulations
Focus on Regulation ·
September 1, 2016
cite
New Guidance Makes Clear that FDA Is Focused on Insanitary Conditions at Pharmacy Compounders
Focus on Regulation ·
August 3, 2016
cite
Previous
1
2
3
4
5
6
Next
